DEL ‐1, as an anti‐neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma
Allergy · 2024
DOI: 10.1111/all.15882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Man Jia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Asthma, Calcium-Binding Proteins, Cell Adhesion Molecules, Neutrophils. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Background
Neutrophil migration into the airways is a key process in neutrophilic asthma. Developmental endothelial locus‐1 (DEL‐1), an extracellular matrix protein, is a neutrophil adhesion inhibitor that attenuates neutrophilic inflammation.
Methods
Levels of DEL‐1 were measured in exhaled breath condensate (EBC) and serum in asthma patients by ELISA. DEL‐1 modulation of neutrophil adhesion and transepithelial migration was examined in a co‐culture model in vitro. The effects of DEL‐1‐adenoviral vector‐mediated overexpression on ovalbumin/lipopolysaccharide (OVA/LPS)‐induced neutrophilic asthma were studied in mice in vivo.
Results
DEL‐1 was primarily expressed in human bronchial epithelial cells and was decreased in asthma patients. Serum DEL‐1 concentrations were reduced in patients with severe asthma compared with normal subjects (567.1 ± 75.3 vs. 276.8 ± 29.36 pg/mL, p < .001) and were negatively correlated to blood neutrophils ( r = −0.2881, p = .0384) and neutrophil‐to‐lymphocyte ratio (NLR) ( r = −0.5469, p < .0001). DEL‐1 concentrations in the EBC of severe asthmatic patients (113.2 ± 8.09 pg/mL) were also lower than normal subjects (193.0 ± 7.61 pg/mL, p < .001) and were positively correlated with the asthma control test (ACT) score ( r = 0.3678, p = .0035) and negatively related to EBC IL‐17 ( r = −0.3756, p = .0131), myeloperoxidase (MPO) ( r = −0.5967, p = .0055), and neutrophil elastase (NE) ( r = −0.5488, p = .0009) expression in asthma patients. Neutrophil adhesion and transepithelial migration in asthma patients were associated with LFA‐1 binding to ICAM‐1 and inhibited by DEL‐1. DEL‐1 mRNA and protein expression in human bronchial epithelial cells were regulated by IL‐17. Exogenous DEL‐1 inhibited IL‐17‐enhanced neutrophil adhesion and migration. DEL‐1 expression was decreased while neutrophil infiltration was increased in the airway of a murine model of neutrophilic asthma. This was prevented by DEL‐1 overexpression.
Conclusions
DEL‐1 down‐regulation leads to increased neutrophil migration across bronchial epithelial cells and is associated with neutrophilic airway inflammation in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Airway Disease Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.
- Department of Allergy, Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Shandong Key Laboratory of Infections Respiratory Disease, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- Department of Respiratory Medicine, Nanjing Red Cross Hospital, Nanjing, China.
ORCID-Profile: Man Jia, Lina Wang, Jiayan Xu, Peter J Barnes, Ian M Adcock, Lei Yao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Jia, M., Fu, H., Jiang, X., Wang, L., Xu, J., Barnes, P. J., Adcock, I. M., Liu, Y., He, S., Zhang, F., Yao, L., Sun, P., & Yao, X. (2024). DEL ‐1, as an anti‐neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma. Allergy. https://doi.org/10.1111/all.15882
Vancouver
Jia M, Fu H, Jiang X, Wang L, Xu J, Barnes PJ, et al. DEL ‐1, as an anti‐neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma. Allergy. 2024. doi:10.1111/all.15882
BibTeX
@article{Jia2024,
author = {Jia, Man and Fu, Heng and Jiang, Xinyu and Wang, Lina and Xu, Jiayan and Barnes, Peter J and Adcock, Ian M and Liu, Yi and He, Shujuan and Zhang, Fan and Yao, Lei and Sun, Peng and Yao, Xin},
title = {DEL ‐1, as an anti‐neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.15882}
}
EUVIMED